Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Hodgkin Disease 7Lymphoma 3Vulvar Neoplasms 1Neoplasms, Second Primary 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1

Interventions

pembrolizumab 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Cisplatin 2entinostat 1bintrafusp alfa protein, human 1Vaccines 1Surveys and Questionnaires 1Specimen Handling 1Papillomavirus Vaccines 1Observation 1Nivolumab 1Ipilimumab 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1CTLA-4 Antigen 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Vulvar Neoplasms × Bleomycin × Clear all
NCT06715592 2025-08-08

ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Active not recruiting
18 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡